停经后骨质疏鬆症治疗市场规模 - 按药物类型（双磷酸盐、荷尔蒙替代疗法 (HRT)）、给药途径、配销通路、全球预测（2023-2032）

由于全球政府支持性措施和医疗保健政策的激增，预计 2023 年至 2032 年停经后骨质疏鬆症治疗市场规模的CAGR为 4.6%。补贴医疗服务、药物负担能力和支持性研发计画的涌入正在创造一个有利于有效骨质疏鬆症管理的环境。此外，政府驱动的法规和指南也显着增加，以确保品质标准和病人安全，同时促进创新治疗方法的整合。

此外，行业参与者不断努力透过开发先进的仿製药配方和设备工程来加强其市场地位，以提高患者获得关键治疗选择的机会，这将增强行业前景。例如，2023 年11 月，Teva Pharmaceutical Industries Ltd. 的美国子公司Teva Pharmaceuticals Inc. 获得批准销售仿製药Forteo (R)1，这是一种含有特立帕肽的注射剂，用于治疗某些男性和女性患者的骨质疏鬆症。

停经后骨质疏鬆症治疗产业按药物类型、给药途径、配销通路和区域细分。

根据药物类型，荷尔蒙替代疗法 (HRT) 领域的市场份额预计在 2023 年至 2032 年间将获得 4.8% 的CAGR。HRT 已成为停经后骨质疏鬆症的有效治疗方法，因为它有助于维持骨密度、减少骨折风险并管理症状。此外，越来越多地采用荷尔蒙替代疗法来治疗停经后女性，再加上持续不断的配方研发工作，将推动该细分市场的扩张。

在配销通路方面，预计到2032年，医院药房领域的停经后骨质疏鬆症治疗行业将实现3.7%的增长率。医院药房是骨质疏鬆症药物的重要分销点，以确保处方治疗的可及性。从医院药房获取药物的便利性以及医院专家医疗保健专业人员的可用性更高，将有助于该细分市场的成长。

从地区来看，在人口老化和骨质疏鬆症管理意识不断提高的推动下，到 2032 年，亚太地区停经后骨质疏鬆症治疗市场预计将呈现 5.2% 的成长率。根据 NCBI 2023 年发布的估计，到 2050 年，亚洲将占骨质疏鬆症引起的所有骨折的一半以上，其中停经后妇女是最脆弱的。该地区停经后妇女骨质疏鬆症盛行率不断上升，预计将刺激对先进疗法的需求。此外，不断增加的医疗保健支出、改善的医疗保健基础设施和政府措施将进一步促进该地区停经后骨质疏鬆症治疗的采用。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：停经后骨质疏鬆症治疗市场洞察

• 产业格局
• 产业影响力
  • 成长动力
    • 老年妇女骨质疏鬆症盛行率不断上升
    • 研发新药审批不断增加
    • 政府倡议
  • 产业陷阱与挑战
    • 治疗依从性
    • 药物的不良反应
  • 成长潜力分析
  • 依药物类型
  • 依给药途径
  • 按配销通路
• COVID-19 影响分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：停经后骨质疏鬆症治疗市场估计与预测：按药物类型，2018-2032

• 主要动向：依药物类型
• 双磷酸盐
• 荷尔蒙替代疗法（HRT）
• 副甲状腺素
• 雌激素受体调节剂
• 其他药物类型

第 6 章：停经后骨质疏鬆症治疗市场估计与预测：依给药途径，2018-2032 年

• 主要动向：按给药途径
• 口服
• 注射用
  • 静脉
  • 肌肉注射
  • 皮下
• 透皮
• 鼻腔

第 7 章：停经后骨质疏鬆症治疗市场估计与预测：按配销通路，2018-2032

• 主要动向：按配销通路
• 医院药房
• 零售药局
• 网路药局

第 8 章：停经后骨质疏鬆症治疗市场估计与预测：按地区，2018 - 2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 9 章：公司简介

• Eli Lilly and Company
• Merck Sharp & Dohme Corp. (Merck & Co., Inc.)
• AbbVie company (Allergan Pharmaceuticals International Ltd.)
• Amgen Inc.
• Theramex(PAI and Carlyle)
• Sun Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Novartis AG
• Mylan Inc.
• Chugai Pharma China Co., Ltd. (Roche)

Postmenopausal Osteoporosis Treatment Market size is estimated to depict 4.6% CAGR from 2023 to 2032 attributed to the surge in supportive government initiatives and healthcare policies worldwide. The influx of subsidized healthcare services, medication affordability, and supportive R&D initiatives are creating an environment conducive to effective osteoporosis management. Additionally, there has been significant increase in government-driven regulations and guidelines for ensuring quality standards and patient safety while promoting the integration of innovative treatment approaches.

Furthermore, the rising efforts by industry players on strengthening their market position through the development of advanced generic formulations and device engineering to enhance patient access to crucial treatment options will augment the industry outlook. For instance, in November 2023, Teva Pharmaceuticals Inc., a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. received approval to market the generic version of Forteo®1, an injectable containing teriparatide, prescribed to treat osteoporosis in certain male and female patients.

The postmenopausal osteoporosis treatment industry is segmented into drug type, route of administration, distribution channel, and region.

Based on drug type, the market share from the hormone replacement therapy (HRT) segment is anticipated to gain 4.8% CAGR between 2023 and 2032. HRT has emerged as an effective treatment approach for postmenopausal osteoporosis as it helps to maintain bone density, reduce fracture risk, and manage symptoms. Additionally, the increasing adoption of hormone replacement therapies to treat postmenopausal women coupled with the ongoing R&D efforts for formulations will propel the segment expansion.

In terms of distribution channel, the postmenopausal osteoporosis treatment industry from the hospital pharmacies segment is estimated to record 3.7% growth rate through 2032. Hospital pharmacies serve as crucial distribution points for osteoporosis medications for ensuring accessibility to prescribed treatments. The convenience of obtaining medications from hospital pharmacies and the higher availability of expert healthcare professionals at hospitals will contribute to the segment growth.

Regionally, the Asia Pacific postmenopausal osteoporosis treatment market is set to exhibit 5.2% growth rate through 2032 driven by the aging population and increasing awareness of osteoporosis management. According to NCBI estimations published in 2023, Asia will account for more than half of all fractures caused by osteoporosis by 2050, with postmenopausal women being the most vulnerable. This rising prevalence of osteoporosis among postmenopausal women across the region is expected to fuel the demand for advanced therapies. Moreover, the rising healthcare expenditure, improving healthcare infrastructure, and government initiatives will further boost the adoption of postmenopausal osteoporosis treatments in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast Calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Postmenopausal osteoporosis treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Drug type trends
  • 2.1.4 Route of administration trends
  • 2.1.5 Distribution channel trends

Chapter 3 Postmenopausal Osteoporosis Treatment Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of osteoporosis among elderly woman population
    • 3.2.1.2 Rising R&D and new drug approvals
    • 3.2.1.3 Government initiatives
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Treatment compliance
    • 3.2.2.2 Adverse effects of medications
  • 3.2.3 Growth potential analysis
  • 3.2.4 By drug type
  • 3.2.5 By route of administration
  • 3.2.6 By distribution channel
• 3.3 COVID-19 impact analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Postmenopausal Osteoporosis Treatment Market Estimates and Forecast, By Drug Type, 2018-2032 (USD Million)

• 5.1 Key trends, by drug type
• 5.2 Bisphosphonates
• 5.3 Hormone replacement therapy (HRT)
• 5.4 Parathyroid hormone
• 5.5 Estrogen receptor modulators
• 5.6 Other drug types

Chapter 6 Postmenopausal Osteoporosis Treatment Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

• 6.1 Key trends, by route of administration
• 6.2 Oral
• 6.3 Parenteral
  • 6.3.1.1 Intravenous
  • 6.3.1.2 Intramuscular
  • 6.3.1.3 Subcutaneous
• 6.4 Transdermal
• 6.5 Nasal

Chapter 7 Postmenopausal Osteoporosis Treatment Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)

• 7.1 Key trends, by distribution channel
• 7.2 Hospital Pharmacies
• 7.3 Retail Pharmacies
• 7.4 Online Pharmacies

Chapter 8 Postmenopausal Osteoporosis Treatment Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Eli Lilly and Company
• 9.2 Merck Sharp & Dohme Corp. (Merck & Co., Inc.)
• 9.3 AbbVie company (Allergan Pharmaceuticals International Ltd.)
• 9.4 Amgen Inc.
• 9.5 Theramex(PAI and Carlyle)
• 9.6 Sun Pharmaceutical Industries Ltd.
• 9.7 Pfizer Inc.
• 9.8 Novartis AG
• 9.9 Mylan Inc.
• 9.10 Chugai Pharma China Co., Ltd. (Roche)

Data Tables

• TABLE 1 Market revenue, by drug type (2022)
• TABLE 2 Market revenue, by route of administration (2022)
• TABLE 3 Market revenue, by distribution channel (2022)
• TABLE 4 Market share, by region (2022)
• TABLE 5 Global postmenopausal osteoporosis treatment market size, by region, 2018 - 2022 (USD Million)
• TABLE 6 Global postmenopausal osteoporosis treatment market size, by region, 2023 - 2032 (USD Million)
• TABLE 7 Global postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 8 Global postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 9 Global postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 10 Global postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 11 Global postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 12 Global postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 13 Industry impact forces
• TABLE 14 Bisphosphonates market size, 2018 - 2022 (USD Million)
• TABLE 15 Bisphosphonates market size, 2023 - 2032 (USD Million)
• TABLE 16 Hormone replacement therapy (HRT) market size, 2018 - 2022 (USD Million)
• TABLE 17 Hormone replacement therapy (HRT) market size, 2023 - 2032 (USD Million)
• TABLE 18 Parathyroid hormone market size, 2018 - 2022 (USD Million)
• TABLE 19 Parathyroid hormone market size, 2023 - 2032 (USD Million)
• TABLE 20 Estrogen receptor modulators market size, 2018 - 2022 (USD Million)
• TABLE 21 Estrogen receptor modulators market size, 2023 - 2032 (USD Million)
• TABLE 22 Other drug type market size, 2018 - 2022 (USD Million)
• TABLE 23 Other drug type market size, 2023 - 2032 (USD Million)
• TABLE 24 Oral market size, 2018 - 2022 (USD Million)
• TABLE 25 Oral market size, 2023 - 2032 (USD Million)
• TABLE 26 Parenteral market size, 2018 - 2022 (USD Million)
• TABLE 27 Parenteral market size, 2023 - 2032 (USD Million)
• TABLE 28 Intravenous market size, 2018 - 2022 (USD Million)
• TABLE 29 Intravenous market size, 2023 - 2032 (USD Million)
• TABLE 30 Intramuscular market size, 2018 - 2022 (USD Million)
• TABLE 31 Intramuscular market size, 2023 - 2032 (USD Million)
• TABLE 32 Subcutaneous market size, 2018 - 2022 (USD Million)
• TABLE 33 Subcutaneous market size, 2023 - 2032 (USD Million)
• TABLE 34 Transdermal market size, 2018 - 2022 (USD Million)
• TABLE 35 Transdermal market size, 2023 - 2032 (USD Million)
• TABLE 36 Nasal market size, 2018 - 2022 (USD Million)
• TABLE 37 Nasal market size, 2023 - 2032 (USD Million)
• TABLE 38 Hospital pharmacies market size, 2018 - 2022 (USD Million)
• TABLE 39 Hospital pharmacies market size, 2023 - 2032 (USD Million)
• TABLE 40 Retail pharmacies market size, 2018 - 2022 (USD Million)
• TABLE 41 Retail pharmacies market size, 2023 - 2032 (USD Million)
• TABLE 42 Online pharmacies market size, 2018 - 2022 (USD Million)
• TABLE 43 Online pharmacies market size, 2023 - 2032 (USD Million)
• TABLE 44 North America postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 45 North America postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 46 North America postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 47 North America postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 48 North America postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 49 North America postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 50 North America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 51 North America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 52 North America postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 53 North America postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 54 U.S. postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 55 U.S. postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 56 U.S. postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 57 U.S. postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 58 U.S. postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 59 U.S. postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 60 U.S. postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 61 U.S. postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 62 Canada postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 63 Canada postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 64 Canada postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 65 Canada postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 66 Canada postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 67 Canada postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 68 Canada postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 69 Canada postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 70 Europe postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 71 Europe postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 72 Europe postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 73 Europe postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 74 Europe postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 75 Europe postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 76 Europe postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 77 Europe postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 78 Europe postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 79 Europe postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 80 Germany postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 81 Germany postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 82 Germany postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 83 Germany postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 84 Germany postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 85 Germany postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 86 Germany postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 87 Germany postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 88 UK postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 89 UK postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 90 UK postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 91 UK postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 92 UK postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 93 UK postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 94 UK postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 95 UK postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 96 France postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 97 France postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 98 France postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 99 France postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 100 France postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 101 France postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 102 France postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 103 France postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 104 Spain postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 105 Spain postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 106 Spain postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 107 Spain postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 108 Spain postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 109 Spain postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 110 Spain postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 111 Spain postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 112 Italy postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 113 Italy postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 114 Italy postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 115 Italy postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 116 Italy postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 117 Italy postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 118 Italy postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 119 Italy postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 120 Rest of Europe postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 121 Rest of Europe postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 122 Rest of Europe postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 123 Rest of Europe postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 124 Rest of Europe postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 125 Rest of Europe postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 126 Rest of Europe postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 127 Rest of Europe postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 128 Asia Pacific postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 129 Asia Pacific postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 130 Asia Pacific postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 131 Asia Pacific postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 132 Asia Pacific postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 133 Asia Pacific postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 134 Asia Pacific postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 135 Asia Pacific postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 136 Asia Pacific postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 137 Asia Pacific postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 138 China postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 139 China postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 140 China postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 141 China postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 142 China postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 143 China postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 144 China postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 145 China postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 146 Japan postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 147 Japan postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 148 Japan postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 149 Japan postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 150 Japan postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 151 Japan postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 152 Japan postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 153 Japan postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 154 India postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 155 India postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 156 India postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 157 India postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 158 India postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 159 India postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 160 India postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 161 India postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 162 Australia postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 163 Australia postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 164 Australia postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 165 Australia postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 166 Australia postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 167 Australia postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 168 Australia postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 169 Australia postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 170 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 171 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 172 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 173 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 174 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 175 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 176 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 177 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 178 Latin America postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 179 Latin America postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 180 Latin America postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 181 Latin America postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 182 Latin America postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 183 Latin America postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 184 Latin America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 185 Latin America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 186 Latin America postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 187 Latin America postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 188 Brazil postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 189 Brazil postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 190 Brazil postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 191 Brazil postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 192 Brazil postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 193 Brazil postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 194 Brazil postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 195 Brazil postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 196 Mexico postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 197 Mexico postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 198 Mexico postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 199 Mexico postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 200 Mexico postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 201 Mexico postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 202 Mexico postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 203 Mexico postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 204 Rest of Latin America postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 205 Rest of Latin America postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 206 Rest of Latin America postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 207 Rest of Latin America postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 208 Rest of Latin America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 209 Rest of Latin America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 210 Rest of Latin America postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 211 Rest of Latin America postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 212 Middle East & Africa postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 213 Middle East & Africa postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 214 Middle East & Africa postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 215 Middle East & Africa postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 216 Middle East & Africa postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 217 Middle East & Africa postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 218 Middle East & Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 219 Middle East & Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 220 Middle East & Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 221 Middle East & Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 222 South Africa postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 223 South Africa postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 224 South Africa postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 225 South Africa postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 226 South Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 227 South Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 228 South Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 229 South Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 230 Saudi Arabia postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 231 Saudi Arabia postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 232 Saudi Arabia postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 233 Saudi Arabia postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 234 Saudi Arabia postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 235 Saudi Arabia postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 236 Saudi Arabia postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 237 Saudi Arabia postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 238 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 239 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 240 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 241 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 242 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
• TABLE 243 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
• TABLE 244 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 245 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Postmenopausal osteoporosis treatment industry 36 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by drug type
• FIG 8 Growth potential analysis, by route of administration
• FIG 9 Growth potential analysis, by distribution channel
• FIG 10 Porter's analysis
• FIG 11 PESTEL analysis
• FIG 12 Company matrix analysis, 2022
• FIG 13 Competitive analysis of major market players, 2022
• FIG 14 Competitive positioning matrix, 2022
• FIG 15 Strategic dashboard, 2022